Home 
Site Map
Site Map
Site Map
- Home
- About the Center
- Research
- Investigators
- Publications
- Translational Research
- Preclinical Development Group Team
- Preclinical Development Projects
- Preclinical Development News
- A Novel Delta Opioid Receptor Antagonist, SoRI-9409, Produces a Selective and Long-Lasting Decrease in Ethanol Consumption in Heavy Drinking Rats
- Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
- Orexin-1 Receptor and Stress-Induced Relapse
- CRF-BP and Ethanol Intake
- Preclinical Model for Ethanol-Mediated Behaviors
- SoRI 9409 and Ethanol Consumption
- Career & Training
- Recent News
- UCSF Researchers Make Headway with Potential Alcoholism Drug
- New Drug Candidate to Treat Alcoholism Hits a Different Target in the Brain
- Many Recovering Alcoholics Depend on Coffee, Cigarettes
- Variability in reward learning performance often translates to life-long patterns of success or failure
- Excessive Drinking and Relapse Rapidly Cut in New Approach
- The Gallo Center awarded prestigious grant from the NIAAA
- Drug to curb smoking also cuts alcohol dependence
- Brain imaging and genetic studies link thinking patterns to addiction
- Morphine dependency blocked by single genetic change
- Alcoholism: Vice or Disease? A Conversation with Howard Fields Part 3 of 3
- UCSF research pinpoints brain molecule's role in developing addiction
- Controversial drug shown to act on brain protein to cut alcohol use
- Links
- UCSF
